| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥816.4B | ¥875.2B | -6.7% |
| Operating Income | ¥98.8B | ¥76.0B | +30.0% |
| Ordinary Income | ¥103.5B | ¥84.0B | +23.3% |
| Net Income | ¥74.4B | ¥53.8B | +38.3% |
| ROE | 20.9% | 17.4% | - |
FY2026 Q3 results: Revenue 81.6B yen (YoY -6.7%), Operating Income 9.9B yen (YoY +30.0%), Ordinary Income 10.4B yen (YoY +23.3%), Net Income 7.4B yen (YoY +38.3%). Despite top-line contraction, the company delivered substantial profit growth through gross margin expansion of 290 basis points to 37.0% and operating margin improvement of 342 basis points to 12.1%. Operating expenses declined in absolute terms while SG&A ratio decreased 50 basis points to 24.9%, demonstrating effective cost discipline. Non-operating gains included FX gains of 0.4B yen, while interest expense remained minimal at 0.09B yen with interest coverage of 111x. ROE reached 20.9%, driven primarily by net margin expansion to 9.1%, asset turnover of 1.106x, and financial leverage of 2.07x. However, operating cash flow of 2.3B yen represented only 31% of net income, primarily due to accounts receivable increase of 7.6B yen and inventory build of 1.2B yen, indicating delayed cash conversion. Free cash flow of 0.3B yen was insufficient to cover shareholder returns of 7.5B yen (dividends 3.0B yen plus share buybacks 4.5B yen) and debt repayment of 2.0B yen, resulting in cash declining 25.9% to 18.0B yen. Full-year guidance projects revenue of 110B yen (-4.9%), operating income of 13B yen (+27.3%), and net income of 9.4B yen, contingent on Q4 margin maintenance and working capital normalization.
[Profitability] ROE 20.9% demonstrates strong capital efficiency, decomposing into net profit margin 9.1%, asset turnover 1.106x, and financial leverage 2.07x. Operating margin improved 342 basis points YoY to 12.1%, driven by gross margin expansion of 290 basis points to 37.0% and SG&A ratio improvement of 50 basis points to 24.9%. EBITDA margin reached 13.7% with EBITDA of 11.2B yen. The five-factor ROE analysis shows tax burden coefficient of 0.743, minimal interest burden coefficient of 1.013, and EBIT margin of 12.1% as the primary ROE driver. Revenue per employee and productivity metrics reflect revenue contraction offset by operational efficiency gains. [Cash Quality] Cash and equivalents 18.0B yen provide 9.02x coverage of short-term debt of 2.0B yen. Operating cash flow to net income ratio of 0.31x indicates weak cash conversion, primarily due to accounts receivable expansion of 66.5% and inventory increase of 28.1%. OCF to EBITDA ratio of 0.21x signals delayed cash realization from earnings. Free cash flow of 0.3B yen yields FCF margin of 0.4%. [Investment Efficiency] Asset turnover of 1.106x remains stable. Capex to depreciation ratio of 1.18x indicates measured growth investment. Working capital expansion, particularly receivables days extension, temporarily constrained asset efficiency. [Financial Health] Equity ratio 48.2% (total equity 35.6B yen of total assets 73.8B yen), current ratio 198.2%, quick ratio 167.5%. Debt to EBITDA 0.80x, debt to capital 20.2%, interest coverage 111x demonstrate robust financial stability. Net debt position remains minimal with cash exceeding short-term borrowings, though total borrowings of 9.0B yen exist including long-term debt of 7.0B yen.
Operating cash flow of 2.3B yen represents 0.31x of net income 7.4B yen, indicating weak cash-backed earnings. The primary detractors were accounts receivable increase of 7.6B yen, inventory increase of 1.2B yen, and other current liabilities decrease of 2.3B yen, reflecting working capital expansion that absorbed operating profit growth. Accounts payable increased 2.7B yen, partially offsetting receivables and inventory builds but insufficient to neutralize the overall working capital drag. Investing cash flow of 2.0B yen comprised primarily capital expenditures with capex to depreciation ratio of 1.18x, maintaining measured reinvestment for renewal and growth. Free cash flow totaled 0.3B yen (operating CF 2.3B yen minus investing CF 2.0B yen), insufficient to cover financing activities. Financing cash flow reflected dividends of approximately 3.0B yen, share buybacks of 4.5B yen totaling 7.5B yen in shareholder distributions, plus long-term debt repayment of 2.0B yen and short-term borrowing reduction of 3.0B yen. Total financing outflows exceeded FCF generation, resulting in cash declining 6.3B yen or 25.9% YoY to 18.0B yen. OCF to EBITDA ratio of 0.21x highlights the substantial gap between accrual-based earnings and cash generation, stemming from extended receivables collection (sales terms or timing shifts) and inventory accumulation (demand softness or mix changes). While financial flexibility remains adequate with cash coverage of short-term liabilities at 9.02x and current ratio of 198%, the sustainability of current shareholder return levels requires near-term improvement in working capital efficiency and cash conversion to rebuild FCF adequacy.
Ordinary income of 10.4B yen versus operating income of 9.9B yen shows non-operating net contribution of approximately 0.5B yen, comprising primarily FX gains of 0.4B yen and minimal interest expense of 0.09B yen. Non-operating income represents 0.5% of revenue, consisting of FX gains as the dominant component with negligible financial income and equity method gains. Interest coverage of 111x indicates immaterial financial expense burden. The non-operating contribution is modest relative to core operating performance, suggesting earnings primarily reflect operating fundamentals rather than financial engineering or one-time gains. However, operating cash flow of 2.3B yen significantly trails net income of 7.4B yen, yielding an OCF to net income ratio of 0.31x, which signals material accruals and raises earnings quality concerns. The divergence stems from accounts receivable expansion of 7.6B yen (66.5% increase) and inventory build of 1.2B yen (28.1% increase), both outpacing revenue trends and indicating either extended payment terms, delayed collections, or demand-supply mismatches. Other current liabilities decreased 2.3B yen, further absorbing cash. Accounts payable increased 2.7B yen, providing partial offset through supplier credit utilization but insufficient to bridge the working capital gap. The low OCF to EBITDA ratio of 0.21x underscores that earnings growth has not yet translated to proportional cash generation. While gross and operating margin improvements to 37.0% and 12.1% respectively reflect genuine profitability enhancement through cost structure optimization, the weak cash conversion limits the sustainability of discretionary activities such as current dividend levels and share buybacks, which together totaled 7.5B yen against FCF of only 0.3B yen. Near-term earnings quality would strengthen materially with normalization of receivables collection cycles and inventory turnover, which management guidance implies for Q4. Absent working capital normalization, the earnings quality remains constrained despite strong accrual profitability metrics.
Demand softness and product cycle delays pose revenue risk, evidenced by 6.7% sales decline and accumulating inventory up 28.1%, potentially requiring pricing concessions or product markdowns that could erode the 290 basis point gross margin gain achieved this quarter. Extended accounts receivable collection with 66.5% YoY increase creates credit exposure and cash flow volatility, particularly if customer financial health deteriorates or payment terms have structurally lengthened, threatening the 0.31x OCF to net income conversion and constraining financial flexibility. Foreign exchange volatility introduces earnings unpredictability, as current period benefited from 0.4B yen FX gains contributing to ordinary income; reversal of yen weakness or hedging ineffectiveness could materially pressure profitability given global revenue mix, with quantifiable impact dependent on currency exposure composition not fully disclosed but material given FX gain magnitude relative to 10.4B yen ordinary income.
[Industry Position] (Reference - Proprietary Analysis)
Profitability: Operating Margin 12.1% substantially exceeds industry median 7.3% (IQR 4.6%-12.0%), ranking in the upper quartile and reflecting effective cost management despite revenue contraction. Net Profit Margin 9.1% significantly outperforms industry median 5.4% (IQR 3.5%-8.9%), indicating superior bottom-line efficiency. ROE 20.9% far exceeds industry median 4.9% (IQR 2.8%-8.2%), driven by margin excellence and moderate leverage deployment.
Financial Health: Current Ratio 198.2% (1.98x) falls below industry median 2.67x (IQR 2.00x-3.56x), positioning near the lower quartile, though absolute liquidity remains adequate with 9.02x cash coverage of short-term debt. Equity Ratio 48.2% trails industry median 63.9% (IQR 51.5%-72.3%), reflecting comparatively higher leverage utilization within acceptable bounds. Net Debt to EBITDA 0.80x compares favorably to industry median -1.11x (IQR -3.50x to 1.24x), as the company carries modest net debt while many peers maintain net cash positions.
Growth: Revenue Growth -6.7% underperforms industry median 2.8% (IQR -0.9% to 7.9%), placing in the bottom quartile and highlighting company-specific demand challenges divergent from sector trends.
Efficiency: Return on Assets 10.1% (calculated as net income 7.4B yen / average total assets 72.3B yen) significantly exceeds industry median 3.3% (IQR 1.8%-5.1%), demonstrating superior asset utilization despite working capital expansion pressures.
Overall, the company demonstrates peer-leading profitability and asset efficiency with ROE and operating margins in top decile, offset by below-median revenue growth and liquidity ratios. The strong margin profile compensates for higher leverage, yielding superior returns. The revenue contraction versus industry growth warrants monitoring, though margin resilience provides near-term earnings cushion.
(Industry: Manufacturing, N=65 companies, Period: 2025-Q3, Source: Proprietary Analysis)
Margin expansion capability demonstrated through 342 basis point operating margin improvement to 12.1% and 290 basis point gross margin gain to 37.0% despite 6.7% revenue decline indicates effective cost structure optimization and pricing discipline, positioning the company to generate substantial operating leverage when revenue growth resumes. ROE of 20.9% substantially exceeds manufacturing sector median of 4.9% and historical company performance, driven by net margin expansion rather than balance sheet leverage, suggesting sustainable profitability improvement if margins stabilize at current levels. Working capital management requires urgent attention as accounts receivable surge of 66.5% and inventory increase of 28.1% compressed operating cash flow to 0.31x net income and free cash flow to 0.3B yen, creating tension with 7.5B yen total shareholder distributions and limiting financial flexibility; Q4 normalization of receivables collection and inventory turnover is critical to validate full-year guidance of 13B yen operating income and restore cash generation adequacy for sustainable capital allocation. Full-year guidance implies Q4 revenue of approximately 28.4B yen and operating income of 3.2B yen, requiring sequential margin compression from Q3's elevated 12.1% to approximately 11% for the quarter, suggesting management conservatism or expectation of mix/pricing pressure that could test profitability sustainability beyond the fiscal year if structural rather than seasonal.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.